KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2025)

Charles River Laboratories International has reported Asset Writedowns and Impairment over the past 4 years, most recently at $7.9 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 70.8% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $12.4 million, down 64.67%, while the annual FY2025 figure was $12.4 million, 15.77% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $7.9 million at Charles River Laboratories International, up from -$26.6 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $29.2 million in Q2 2025 and troughed at -$26.6 million in Q3 2025.
  • A 4-year average of $5.6 million and a median of $6.7 million in 2022 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 1543.21% in 2024 and later tumbled 342.08% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $6.7 million in 2022, then tumbled by 218.95% to -$8.0 million in 2023, then soared by 438.47% to $27.0 million in 2024, then crashed by 70.8% to $7.9 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for CRL at $7.9 million in Q4 2025, -$26.6 million in Q3 2025, and $29.2 million in Q2 2025.